Holen Sie sich die Stockscreener-App
182.65
6.88%
-13.50
Schlusskurs vom Vortag:
$196.15
Offen:
$195.69
24-Stunden-Volumen:
1.06M
Relative Volume:
0.94
Marktkapitalisierung:
$25.89B
Einnahmen:
$2.31B
Nettoeinkommen (Verlust:
$-208.16M
KGV:
-118.87
EPS:
-1.5366
Netto-Cashflow:
$76.11M
1W Leistung:
-6.47%
1M Leistung:
-12.20%
6M Leistung:
+12.08%
1J Leistung:
+23.16%
1-Tages-Spanne:
$181.00
$195.99
1-Wochen-Bereich:
$181.00
$202.88
52-Wochen-Spanne:
$125.38
$256.36
Natera Inc Stock (NTRA) Company Profile
Firmenname
Natera Inc
Sektor
Branche
Telefon
650-249-9090
Adresse
13011 MCCALLEN PASS, AUSTIN, CA
Compare NTRA vs TMO, DHR, IDXX, A, WAT
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
NTRA
Natera Inc
|
182.65 | 25.89B | 2.31B | -208.16M | 76.11M | -1.5366 |
TMO
Thermo Fisher Scientific Inc
|
473.36 | 175.85B | 44.56B | 6.72B | 6.29B | 17.74 |
DHR
Danaher Corp
|
181.52 | 128.46B | 24.57B | 3.60B | 5.26B | 5.051 |
IDXX
Idexx Laboratories Inc
|
558.32 | 44.46B | 4.30B | 1.06B | 1.04B | 13.08 |
A
Agilent Technologies Inc
|
110.24 | 31.15B | 7.07B | 1.29B | 993.00M | 4.5355 |
WAT
Waters Corp
|
289.16 | 28.37B | 3.17B | 642.63M | 516.49M | 10.77 |
Natera Inc Stock (NTRA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-01-07 | Eingeleitet | Citigroup | Buy |
| 2025-12-02 | Fortgesetzt | Morgan Stanley | Overweight |
| 2025-10-27 | Hochstufung | BNP Paribas Exane | Underperform → Neutral |
| 2025-09-22 | Fortgesetzt | Wells Fargo | Equal Weight |
| 2025-03-13 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2025-01-23 | Eingeleitet | Barclays | Overweight |
| 2024-06-03 | Fortgesetzt | Jefferies | Buy |
| 2024-04-08 | Fortgesetzt | Craig Hallum | Buy |
| 2024-02-20 | Herabstufung | Raymond James | Strong Buy → Outperform |
| 2023-12-29 | Bestätigt | BTIG Research | Buy |
| 2023-12-14 | Eingeleitet | Guggenheim | Buy |
| 2023-12-13 | Eingeleitet | Wolfe Research | Outperform |
| 2023-11-13 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2023-09-28 | Eingeleitet | Bernstein | Mkt Perform |
| 2023-07-05 | Fortgesetzt | JP Morgan | Overweight |
| 2023-05-05 | Eingeleitet | UBS | Buy |
| 2023-01-18 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2022-08-25 | Eingeleitet | Credit Suisse | Outperform |
| 2022-04-25 | Eingeleitet | Stephens | Overweight |
| 2022-03-08 | Eingeleitet | Goldman | Buy |
| 2022-01-06 | Fortgesetzt | Piper Sandler | Overweight |
| 2021-10-15 | Fortgesetzt | Cowen | Outperform |
| 2021-06-15 | Eingeleitet | Raymond James | Mkt Perform |
| 2021-05-25 | Eingeleitet | Wells Fargo | Overweight |
| 2021-01-28 | Eingeleitet | Truist | Buy |
| 2020-10-08 | Eingeleitet | BTIG Research | Buy |
| 2020-09-28 | Eingeleitet | Morgan Stanley | Overweight |
| 2020-09-17 | Eingeleitet | SVB Leerink | Outperform |
| 2020-06-10 | Fortgesetzt | Piper Sandler | Overweight |
| 2020-05-07 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2018-10-05 | Eingeleitet | JP Morgan | Neutral |
| 2018-07-05 | Bestätigt | Piper Jaffray | Overweight |
| 2017-08-07 | Bestätigt | Morgan Stanley | Overweight |
| 2016-11-10 | Bestätigt | The Benchmark Company | Buy |
| 2016-05-23 | Bestätigt | The Benchmark Company | Buy |
| 2016-05-11 | Bestätigt | The Benchmark Company | Buy |
| 2016-04-19 | Eingeleitet | The Benchmark Company | Buy |
| 2015-09-28 | Hochstufung | Wedbush | Neutral → Outperform |
| 2015-08-14 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2015-08-04 | Eingeleitet | Robert W. Baird | Outperform |
| 2015-07-27 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2015-07-27 | Eingeleitet | Piper Jaffray | Overweight |
| 2015-07-27 | Eingeleitet | Wedbush | Neutral |
Alle ansehen
Natera Inc Aktie (NTRA) Neueste Nachrichten
DAVENPORT & Co LLC Takes Position in Natera, Inc. $NTRA - MarketBeat
Natera, Inc. $NTRA Shares Sold by Assenagon Asset Management S.A. - MarketBeat
A Look At Natera (NTRA) Valuation After Recent Share Price Weakness - simplywall.st
Sentiment Review: What is the next catalyst for Natera IncCEO Change & Technical Entry and Exit Alerts - baoquankhu1.vn
Why Natera’s Stock Is Suddenly Sinking Hard - TipRanks
Elanco, Tandem Diabetes, Fortrea, Natera, and Myriad Genetics Shares Plummet, What You Need To Know - TradingView
Vanguard disaggregates holdings; reports 0 shares for Natera (NTRA) - Stock Titan
Wealth Enhancement Advisory Services LLC Has $11.48 Million Stock Position in Natera, Inc. $NTRA - MarketBeat
Meme Stocks: Is now the right time to enter Natera Inc2026 Closing Moves & Free Fast Gain Swing Trade Alerts - baoquankhu1.vn
Natera Sees Relative Strength Rating Improve To 73 - Investor's Business Daily
$8.25M Natera prenatal screening class action settlement - Class Action Lawsuits
Natera (NTRA) launches Zenith genomic assay - MSN
Is It Time To Reassess Natera (NTRA) After Its Recent Share Price Pullback - simplywall.st
If You Invested $1000 In Natera Stock 10 Years Ago, You Would Have This Much Today - Sahm
Natera (NTRA) Launches Zenith Genomic Assay - Insider Monkey
Systrade AG Buys Shares of 50,000 Natera, Inc. $NTRA - MarketBeat
Natera, Inc. (NASDAQ:NTRA) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat
DEEPWATER ASSET MANAGEMENT, LLC's Natera Inc(NTRA) Holding History - GuruFocus
Natera Inc (NTRA) Stock Price Up 2.86% on Mar 23 - GuruFocus
Natera, Inc.(NasdaqGS: NTRA) added to FTSE All-World Index - marketscreener.com
Natera co-founder Jonathan Sheena sells shares worth $908,301 By Investing.com - Investing.com Canada
Natera co-founder Jonathan Sheena sells shares worth $908,301 - Investing.com UK
Natera Inc (NTRA) Shares Gap Down to $196.73 on Mar 20 - GuruFocus
Natera (NASDAQ: NTRA) co-founder reports 4,570-share planned stock sale - Stock Titan
Form 144 Natera For: 20 March By Investing.com - Investing.com South Africa
Form 144 Natera For: 20 March - Investing.com
Jonathan Sheena reports multiple share sales for NTRA (NASDAQ: NTRA) - Stock Titan
Discipline and Rules-Based Execution in NTRA Response - Stock Traders Daily
Natera's 87.71% Trading Volume Spike Pushes 475th Market Rank as Shares Fall 3.67% Amid Earnings Optimism and Insider Selling - Bitget
CIBC Private Wealth Group LLC Buys 53,086 Shares of Natera, Inc. $NTRA - MarketBeat
Does Natera’s (NTRA) Expanded Genomics Suite Quietly Redefine Its Long-Term Competitive Moat? - simplywall.st
Groupama Asset Managment Has $12.42 Million Stock Holdings in Natera, Inc. $NTRA - MarketBeat
Morgan Stanley Maintains Natera (NTRA) Overweight Recommendation - MSN
Unveiling Natera (NTRA) Q4 outlook: Wall Street estimates for key metrics - MSN
Jonathan Sheena files Rule 144 notice selling shares (NASDAQ: NTRA) - Stock Titan
Natera, Inc. (NTRA) reports preliminary Q4 revenue - MSN
Faithward Advisors LLC Invests $3.52 Million in Natera, Inc. $NTRA - MarketBeat
Livforsakringsbolaget Skandia Omsesidigt Buys 17,100 Shares of Natera, Inc. $NTRA - MarketBeat
JP Morgan lifts Natera, Inc. (NTRA) target on Signatera momentum - MSN
Insider Selling: Natera (NASDAQ:NTRA) Director Sells 122 Shares of Stock - MarketBeat
Natera director Chapman sells $23348 in shares - Investing.com
Natera director Chapman sells $23348 in shares By Investing.com - Investing.com Australia
Natera (NTRA) director sells 122 shares under 10b5-1 trading plan - Stock Titan
Natera Looks Compelling As Oncology Testing Momentum Keeps Building (NASDAQ:NTRA) - Seeking Alpha
Natera named Healthcare Technology Company of the Year - The Healthcare Technology Report.
A Look At Natera (NTRA) Valuation After New Signatera Data And Zenith Genomics Launch - Yahoo Finance
Assessing Natera (NTRA) Valuation After New Signatera Data And Zenith Genomics Launch - simplywall.st
Holocene Advisors LP Decreases Stock Holdings in Natera, Inc. $NTRA - MarketBeat
Boothbay Fund Management LLC Increases Position in Natera, Inc. $NTRA - MarketBeat
Natera executive chairman sells $38.3 million in NTRA stock - Investing.com
Natera executive chairman sells $38.3 million in NTRA stock By Investing.com - Investing.com South Africa
Finanzdaten der Natera Inc-Aktie (NTRA)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.99%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):